Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
- 16 January 2006
- Vol. 24 (3), 221-228
- https://doi.org/10.1016/j.vaccine.2005.07.084
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- The immune Response to the Capsular Polysaccharide of Neisseria meningitidis Group BZentralblatt für Bakteriologie, 1997
- Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteinsVaccine, 1991
- Interaction of meningococcal group B monoclonal antibody and its Fab fragment with α2-8-linked sialic acid polymers: Requirement of a long oligosaccharide segment for bindingMolecular Immunology, 1989
- Developmentally regulated expression of the neural cell adhesion molecule (NCAM) by mouse thymocytesEuropean Journal of Immunology, 1989
- An Epidemic Outbreak of Group B Meningococcal Disease on the Faroe IslandsScandinavian Journal of Infectious Diseases, 1988
- Human Monoclonal Antibody with Protective Activity for Escherichia coli K1 and Neisseria meningitidis Group B InfectionsThe Journal of Infectious Diseases, 1987
- Killing of Neisseria meningitidis by Human Neutrophils: Implications for Normal and Complement-Deficient IndividualsThe Journal of Infectious Diseases, 1987
- A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM.The Journal of cell biology, 1986
- A human monoclonal macroglobulin with specificity for alpha(2----8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA.The Journal of Experimental Medicine, 1986
- The Alternative Pathway of Complement — A System for Host Resistance to Microbial InfectionNew England Journal of Medicine, 1980